Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
- Status
- TERMINATED
- Phase
- PHASE3
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
- Status
- TERMINATED
- Phase
- NA
Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines
- Status
- TERMINATED
- Phase
- PHASE2
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
- Status
- COMPLETED
- Phase
- N/A
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
3D Prediction of Patient-Specific Response
- Status
- UNKNOWN
- Phase
- N/A
Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Immunotherapy Trial for Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
An Expanded Access Program for AM0010 (Pegilodecakin)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A